
Congress trades
Intra-Cellular Therapies, Inc. (ITCI)
NASDAQ · Healthcare · 8 congress trades · last filed 1 year agono longer trading under this ticker
About Intra-Cellular Therapies, Inc.
from the company's filings and listing, as of Oct 25, 2026- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Chief executive
- -
- Employees
- 860
- Listed since
- Jan 7, 2014
- Market value
- $14.0Blast quoted Apr 2, 2025
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -
- Dividend yield
- -
www.intracellulartherapies.com
Earnings
6 reported quarters| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q4 FY2024reported Feb 21, 2025 | -$0.16 | -$0.08 | $199.2M | $193.4M | EPS missRevenue beat |
| Q3 FY2024reported Oct 30, 2024 | -$0.25 | -$0.18 | $175.2M | $194.0M | EPS missRevenue miss |
| Q2 FY2024reported Aug 7, 2024 | -$0.16 | -$0.18 | $161.4M | $157.9M | EPS beatRevenue beat |
| Q1 FY2024reported May 7, 2024 | -$0.16 | -$0.31 | $144.9M | $141.4M | EPS beatRevenue beat |
| Q4 FY2023reported Feb 22, 2024 | -$0.30 | -$0.44 | $131.5M | $135.7M | EPS beatRevenue miss |
| Q3 FY2023reported Nov 2, 2023 | -$0.25 | -$0.59 | $125.8M | $136.9M | EPS beatRevenue miss |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Congress trades in ITCI
8 disclosures of 8 on record · median 22d of the 45 allowedSince the trade: the stock's move from its estimated entry price (a purchase) or estimated exit price (a sale) to its current price, the latest close we hold. Not the member's result.
| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Apr 2, 2025 | Apr 3, 2025 | May 14, 2025 | 41d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Apr 2, 2025 | Apr 3, 2025 | May 6, 2025 | 33d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Apr 2, 2025 | Mar 17, 2025 | Apr 10, 2025 | 24d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Apr 2, 2025 | Mar 24, 2025 | Apr 7, 2025 | 14d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Apr 2, 2025 | Jan 24, 2025 | Feb 10, 2025 | 17d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | n/aPrice history ends Apr 2, 2025 | Jun 21, 2024 | Jul 9, 2024 | 18d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Apr 2, 2025 | Dec 21, 2021 | Jan 10, 2022 | 20d |
| Roger MarshallDependent child | Stock | Purchase | $1,001 - $15,000 | n/aPrice history ends Apr 2, 2025 | May 1, 2017 | Aug 6, 2018 | 462d |
We hold no closing prices for any row shown here, so no move is shown. Not investment advice.
Estimated prices are the stock's closing price on the trade date. A disclosure gives a value band, not the price paid. Not investment advice. After a sale a positive figure means the stock kept rising after it. On an option line the prices are the stock's, never the option's: the premium is never disclosed.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no prices or move are shown for that row.
Every Congress trade in ITCI, filterable by party, chamber, type and account.
Questions
Which members of Congress have traded ITCI?
Josh Gottheimer, Gilbert Ray Cisneros, Jr. and Roger Marshall disclosed ITCI transactions in the filings shown here.
How quickly are ITCI trades disclosed?
Congressional disclosures took a median of 22 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 27, 2026.
